<p>Compounds of formula (I) or pharmaceutically acceptable salts thereof, exhibit 5-HT<sub>1A</sub> agonism in addition to noradrenaline reuptake inhibition and optionally also 5-HT reuptake inhibition are useful for the treatment of obesity.</p>
申请公布号
MX2007009526(A)
申请公布日期
2007.09.26
申请号
MX20070009526
申请日期
2006.02.08
申请人
PROSIDION LIMITED
发明人
GERARD HUGH THOMAS;OSCAR BARBA;GRAHAM JOHN DAWSON;THOMAS MARTIN KRULLE;ROBERT JOHN ROWLEY;DONALD SMYTH
